[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @LSciStartupNews LifeSci Startup LifeSci Startup posts on X about $100m, abingworth, strong, $mirm the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1492531068783800325/interactions)  - X Week XXX -XXXX% - X Month XXXXX -XX% - X Months XXXXXX +2,984% - X Year XXXXXX +532% ### Mentions: X [#](/creator/twitter::1492531068783800325/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XX +867% - X Year XX +252% ### Followers: XXX [#](/creator/twitter::1492531068783800325/followers)  - X Week XXX no change - X Month XXX +1.90% - X Months XXX +9.60% - X Year XXX +14% ### CreatorRank: undefined [#](/creator/twitter::1492531068783800325/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) [vc firms](/list/vc-firms) **Social topic influence** [$100m](/topic/$100m), [abingworth](/topic/abingworth), [strong](/topic/strong), [$mirm](/topic/$mirm), [$820m](/topic/$820m), [$250m](/topic/$250m), [$370m](/topic/$370m), [$200m](/topic/$200m), [$47m](/topic/$47m), [ai](/topic/ai) **Top assets mentioned** [Mirum Pharmaceuticals, Inc. Common Stock (MIRM)](/topic/$mirm) ### Top Social Posts Top posts by engagements in the last XX hours "Iambic Therapeutics has raised $100M+ to advance AI-designed medicines backed by investors including Abingworth Mubadala and Sequoia. The funding supports upcoming clinical programs and follows strong IAM1363 data and a new Jazz Pharma partnership" [X Link](https://x.com/LSciStartupNews/status/1988668114784100694) 2025-11-12T18:00Z XXX followers, XXX engagements "$MIRM is acquiring Bluejay Therapeutics in a deal worth up to $820M to add a late-stage asset for hepatitis D. The deal includes $250M cash $370M in stock and up to $200M in milestones. Lead asset brelovitug has Phase X data expected in 2H 2026" [X Link](https://x.com/LSciStartupNews/status/1998505432579752280) 2025-12-09T21:30Z XXX followers, XX engagements "PsiThera has spun out of Roivant with $47M in Series A funding and its QUAISAR platform that uses physics AI and supercomputing to accelerate early drug discovery before lab work begins. Roivant continues to back the company. More:" [X Link](https://x.com/LSciStartupNews/status/1998908357131022419) 2025-12-11T00:11Z XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@LSciStartupNews LifeSci StartupLifeSci Startup posts on X about $100m, abingworth, strong, $mirm the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence finance vc firms
Social topic influence $100m, abingworth, strong, $mirm, $820m, $250m, $370m, $200m, $47m, ai
Top assets mentioned Mirum Pharmaceuticals, Inc. Common Stock (MIRM)
Top posts by engagements in the last XX hours
"Iambic Therapeutics has raised $100M+ to advance AI-designed medicines backed by investors including Abingworth Mubadala and Sequoia. The funding supports upcoming clinical programs and follows strong IAM1363 data and a new Jazz Pharma partnership"
X Link 2025-11-12T18:00Z XXX followers, XXX engagements
"$MIRM is acquiring Bluejay Therapeutics in a deal worth up to $820M to add a late-stage asset for hepatitis D. The deal includes $250M cash $370M in stock and up to $200M in milestones. Lead asset brelovitug has Phase X data expected in 2H 2026"
X Link 2025-12-09T21:30Z XXX followers, XX engagements
"PsiThera has spun out of Roivant with $47M in Series A funding and its QUAISAR platform that uses physics AI and supercomputing to accelerate early drug discovery before lab work begins. Roivant continues to back the company. More:"
X Link 2025-12-11T00:11Z XXX followers, XX engagements
/creator/x::LSciStartupNews